Autologous Conditioned Plasma (ACP) for Patients With Plantar Fasciitis

NAUnknownINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Chronic Plantar Fasciitis
Interventions
PROCEDURE

ACP

Within two weeks of the initial visit, the RN, will retrieve a 10-12 mL blood sample from all patients. After the sample is retrieved, the patient will be asked to lie prone on the plinth to assist with blinding. The blood sample will be retained in the Arthrex ABS-10010S Double Syringe with Syringe Cap and then separated using a soft spin centrifuge for 5 min at 1500 rpm/rcf. Three to four mL of platelet rich plasma will be pulled into a smaller syringe that is wrapped in opaque tape to conceal the contents of the syringe. The ACP is injected into the torn region of the tendon.

DRUG

Corticosteroid (celestone) injection

Preparation of the blood sample is identical for patients in this group except that the blood sample will ultimately be discarded instead of injected. The syringe is blinded with opaque tape making it identical to the ACP group syringe and injected into the torn area of the tendon.

Trial Locations (1)

N6A 3K7

RECRUITING

Fowler Kennedy Sport Medicine Clinic, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Arthrex, Inc.

INDUSTRY

lead

University of Western Ontario, Canada

OTHER

NCT01614223 - Autologous Conditioned Plasma (ACP) for Patients With Plantar Fasciitis | Biotech Hunter | Biotech Hunter